IFN-β1 is produced through the TRIF-dependent pathway by TLR4 or TLR3 activation (Takeuchi & Akira, 2010), and inhibition of IFN-β1 signaling reduces the mortality after CLP-induced sepsis (Dejager et al, 2014). The gene discussed is TLR4; the disease is Sepsis.